These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 7034562)

  • 41. A prospective study of the epidemiology and ecology of Lassa fever.
    McCormick JB; Webb PA; Krebs JW; Johnson KM; Smith ES
    J Infect Dis; 1987 Mar; 155(3):437-44. PubMed ID: 3805771
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Density dependence and persistence of Morogoro arenavirus transmission in a fluctuating population of its reservoir host.
    Mariën J; Borremans B; Verhaeren C; Kirkpatrick L; Gryseels S; Goüy de Bellocq J; Günther S; Sabuni CA; Massawe AW; Reijniers J; Leirs H
    J Anim Ecol; 2020 Feb; 89(2):506-518. PubMed ID: 31545505
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prevalence of Lassa virus among rodents trapped in three South-South States of Nigeria.
    Agbonlahor DE; Erah A; Agba IM; Oviasogie FE; Ehiaghe AF; Wankasi M; Eremwanarue OA; Ehiaghe IJ; Ogbu EC; Iyen RI; Abbey S; Tatfeng MY; Uhunmwangho J
    J Vector Borne Dis; 2017; 54(2):146-150. PubMed ID: 28748835
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Mixed sero-epidemiologic study of arbovirus-arenavirus in the small mammals of Tunisia].
    Chastel C; Rogues G; Beaucournu-Saguez F; Hellal H; Le Goff F; Beaucournu JC
    Bull Soc Pathol Exot Filiales; 1977; 70(5):471-9. PubMed ID: 615674
    [TBL] [Abstract][Full Text] [Related]  

  • 45. General Molecular Strategy for Development of Arenavirus Live-Attenuated Vaccines.
    Iwasaki M; Ngo N; Cubitt B; Teijaro JR; de la Torre JC
    J Virol; 2015 Dec; 89(23):12166-77. PubMed ID: 26401045
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Determination of arenavirus antigens and antibodies by solid-phase radioimmunological analysis].
    Rezapkin GV; Tkachenko EA; Ivanov AP; Bashkirtsev VN; Dzagurova TK
    Vopr Virusol; 1981; (4):459-62. PubMed ID: 7029908
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Identification of Ippy as a Lassa-fever-related virus.
    Swanepoel R; Leman PA; Shepherd AJ; Shepherd SP; Kiley MP; McCormick JB
    Lancet; 1985 Mar; 1(8429):639. PubMed ID: 2857974
    [No Abstract]   [Full Text] [Related]  

  • 48. Lassa virus antibodies in hospital personnel in western Liberia.
    Frame JD; Casals J; Dennis EA
    Trans R Soc Trop Med Hyg; 1979; 73(2):219-24. PubMed ID: 382467
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Viremia and antibody response of small African and laboratory animals to Crimean-Congo hemorrhagic fever virus infection.
    Shepherd AJ; Leman PA; Swanepoel R
    Am J Trop Med Hyg; 1989 May; 40(5):541-7. PubMed ID: 2499205
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Viral haemorrhagic fever antibodies in Zimbabwe schoolchildren.
    Blackburn NK; Searle L; Taylor P
    Trans R Soc Trop Med Hyg; 1982; 76(6):803-5. PubMed ID: 6761909
    [No Abstract]   [Full Text] [Related]  

  • 51. A Vaccine Platform against Arenaviruses Based on a Recombinant Hyperattenuated Mopeia Virus Expressing Heterologous Glycoproteins.
    Carnec X; Mateo M; Page A; Reynard S; Hortion J; Picard C; Yekwa E; Barrot L; Barron S; Vallve A; Raoul H; Carbonnelle C; Ferron F; Baize S
    J Virol; 2018 Jun; 92(12):. PubMed ID: 29593043
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical virology of Lassa fever in hospitalized patients.
    Johnson KM; McCormick JB; Webb PA; Smith ES; Elliott LH; King IJ
    J Infect Dis; 1987 Mar; 155(3):456-64. PubMed ID: 3805773
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mastomys natalensis and Lassa fever, West Africa.
    Lecompte E; Fichet-Calvet E; Daffis S; Koulémou K; Sylla O; Kourouma F; Doré A; Soropogui B; Aniskin V; Allali B; Kouassi Kan S; Lalis A; Koivogui L; Günther S; Denys C; ter Meulen J
    Emerg Infect Dis; 2006 Dec; 12(12):1971-4. PubMed ID: 17326956
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Characteristics of monoclonal antibodies against Lassa virus].
    Vladyko AS; Bystrova SI; Lemeshko NN; Lukashevich IS
    Mol Gen Mikrobiol Virusol; 1987 May; (5):37-40. PubMed ID: 2441254
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Immunofluorescent anti-Junin virus antibodies in Argentine hemorrhagic fever.
    Cossio PM; Rabinovich A; Maiztegui JI; Carballal G; Casanova MB; Ritacco V; Arana RM
    Intervirology; 1979; 12(1):26-31. PubMed ID: 227813
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Arenavirus Dynamics in Experimentally and Naturally Infected Rodents.
    Mariën J; Borremans B; Gryseels S; Broecke BV; Becker-Ziaja B; Makundi R; Massawe A; Reijniers J; Leirs H
    Ecohealth; 2017 Sep; 14(3):463-473. PubMed ID: 28616660
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Host evolution in Mastomys natalensis (Rodentia: Muridae): An integrative approach using geometric morphometrics and genetics.
    Lalis A; Evin A; Janier M; Koivogui L; Denys C
    Integr Zool; 2015 Nov; 10(6):505-14. PubMed ID: 26331855
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Dynamics of antigen and antibody accumulation in adult mice, infected with Lassa virus].
    Vladyko AS; Surikova LE; Kramarenko LP; Bystrova SI; Torop AV
    Vopr Virusol; 1989; 34(1):100-3. PubMed ID: 2658319
    [No Abstract]   [Full Text] [Related]  

  • 59. [The indirect hemagglutination reaction for the detection of the Lassa virus].
    Vladyko AS; Kramarenko LP; Cherednichenko IA; Surikova LE
    Vopr Virusol; 1988; 33(4):498-502. PubMed ID: 3195147
    [No Abstract]   [Full Text] [Related]  

  • 60. Rodent control to fight Lassa fever: Evaluation and lessons learned from a 4-year study in Upper Guinea.
    Mari Saez A; Cherif Haidara M; Camara A; Kourouma F; Sage M; Magassouba N; Fichet-Calvet E
    PLoS Negl Trop Dis; 2018 Nov; 12(11):e0006829. PubMed ID: 30399142
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.